Yongwei Q. Sun

Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

OSBPL10 Drives Lipophagy-Mediated Lipid Mobilization to Promote Pancreatic Ductal Adenocarcinoma Progression.

OSBPL10 Drives Lipophagy-Mediated Lipid Mobilization to Promote Pancreatic Ductal Adenocarcinoma Progression.

Journal: International journal of biological sciences

Published: September 20, 2025

A Malignant Subpopulation of H2AFZ+ Cells Interacts with Myeloid Cells to Promote an Anti-inflammatory Microenvironment and Drive Hepatic Metastasis, Revealing an Immunotherapeutic Strategy for Pancreatic Ductal Adenocarcinoma.

A Malignant Subpopulation of H2AFZ+ Cells Interacts with Myeloid Cells to Promote an Anti-inflammatory Microenvironment and Drive Hepatic Metastasis, Revealing an Immunotherapeutic Strategy for Pancreatic Ductal Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 04, 2025

LY6D identifies persistent stem-like cells driving pancreatic tumourigenesis.

LY6D identifies persistent stem-like cells driving pancreatic tumourigenesis.

Journal: Gut

Published: July 23, 2025

Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer.

Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer.

Journal: Clinical and translational medicine

Published: October 30, 2024

TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis.

TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis.

Journal: International journal of biological sciences

Published: October 03, 2024

Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer.

Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer.

Journal: Scientific reports

Published: September 14, 2024

MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer.

MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer.

Journal: Gut

Published: March 07, 2024

SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer.

SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 02, 2024

Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study.

Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study.

Journal: Digestive diseases and sciences

Published: November 29, 2023

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.

Journal: Cancer cell

Published: August 15, 2023

Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms.

Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms.

Journal: Chinese medical journal

Published: May 17, 2023

An unusual case of isolated serum γ-glutamyl transferase elevation: slight abnormality also should not be taken lightly.

An unusual case of isolated serum γ-glutamyl transferase elevation: slight abnormality also should not be taken lightly.

Journal: Endoscopy

Published: May 10, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026